Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists

• Tao Liu ,

  * E-mail: Lt601@zju.edu.cn (TL); znm2000@yahoo.com (NZ); Huyz@zju.edu.cn (YH)

  Affiliation Zhejiang University-École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

  ⨯
• Zhiyong Weng,

  Current address: Hangzhou No.2 High School of Zhejiang Province, Hangzhou, China

  Affiliation Zhejiang University-École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

  ⨯
• Xiaowu Dong,

  Affiliation Zhejiang University-École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

  ⨯
• Linjie Chen,

  Affiliation Institute of Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou, China

  ⨯
• Ling Ma,

  Affiliations Insititute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing, China, Peking Union Medical College, Beijing, China

  ⨯
• Shan Cen,

  Affiliations Insititute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing, China, Peking Union Medical College, Beijing, China

  ⨯
• Naiming Zhou ,

  * E-mail: Lt601@zju.edu.cn (TL); znm2000@yahoo.com (NZ); Huyz@zju.edu.cn (YH)

  Affiliation Institute of Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou, China

  ⨯
• Yongzhou Hu

  * E-mail: Lt601@zju.edu.cn (TL); znm2000@yahoo.com (NZ); Huyz@zju.edu.cn (YH)

  Affiliation Zhejiang University-École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

  ⨯